CT and MR product developments helped contrast injector technology firm Medrad achieve a 10% increase in revenues in 2007.
Revenues reached $525 million, up from the $478 million recorded in 2006, according to the Indianola, PA-based firm. The company said it has achieved double-digit annual revenue growth for more than 10 years.
Related Reading
Covidien settles Medrad litigation, February 14, 2008
Medrad to buy Possis Medical, February 11, 2008
Road to RSNA, MRI, Medrad, October 29, 2007
Road to RSNA, CT, Medrad, October 22, 2007
Premier awards imaging contracts, October 4, 2007
Copyright © 2008 AuntMinnie.com